巨騰國際(03336.HK)2024年度淨虧損擴大至5.30億港元
格隆匯3月28日丨巨騰國際(03336.HK)公佈年度業績,2024監督,收入約爲60.26億港元,同比下跌約13.1%;毛利約爲1.73億港元,同比下跌約65.9%;公司股權持有人應佔虧損約爲5.30億港元,2023年度公司股權持有人應佔虧損約爲2.31億港元。每股基本虧損約爲62.7港仙。
儘管集團於年內積極優化業務策略、控制成本、並透過優化現有資源以應對市場挑戰,集團於2024年度毛利率下跌至約2.9%,主要由於產能利用率較低所致。由於銷售收入下降及產能利用率較低,集團錄得物業、廠房及設備減值大幅增加至約3.04億港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.